FDA approves Eli Lilly diabetes drug
![Photo: MIKE SEGAR/REUTERS / X90033](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13731358.ece/ALTERNATES/schema-16_9/doc7jojxhmsz0g11hns92qd.jpg)
On Friday, US-based pharmaceutical firm Eli Lilly could announce that the US Food and Drug Administration (FDA) has approved tirzepatide for patients with type 2 diabetes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Eli Lilly wants to gain on Novo Nordisk's obesity lead
For subscribers